Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

February 27, 2024

Study Completion Date

February 27, 2024

Conditions
Nasal PackingDexmedetomidineTurbinate
Interventions
DRUG

Nasal packing Dexmedetomidine

patients will receive nasal packing Dexmedetomidine (1.5 μg/kg intranasal dexmedetomidine diluted with saline) and Intravenous infusion saline.

DRUG

Intravenous Dexmedetomidine

patients will receive 0.5 μg/kg bolus over 10 min then 0.1- 0.4 μg/kg Intravenous infusion Dexmedetomidine and nasal packing with saline.

Trial Locations (1)

33516

Karelsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT05911776 - Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries | Biotech Hunter | Biotech Hunter